Literature DB >> 18367021

Severe paroxysmal hypertension (pseudopheochromocytoma).

Samuel J Mann1.   

Abstract

Paroxysmal hypertension always engenders a search for a catecholamine-secreting pheochromocytoma. Yet 98% of people with paroxysmal hypertension do not have this tumor. The cause and management of paroxysmal hypertension remain a mystery, and the subject of remarkably few papers. This review presents an approach to understanding and successfully treating this disorder. Patients experience symptomatic blood pressure surges likely linked to sympathetic nervous system stimulation. A specific personality profile associated with this disorder suggests a psychological basis, attributable to repressed emotion related to prior emotional trauma or a repressive (nonemotional) coping style. Based on this understanding, three forms of intervention, alone or in combination, appear successful: antihypertensive therapy with agents directed at the sympathetically mediated blood pressure elevation (eg, combined alpha- and beta-blockade or central alpha-agonists such as clonidine); psychopharmacologic interventions including anxiolytic and/or antidepressant agents; and psychological intervention, particularly reassurance and increased psychological awareness. An appropriately selected intervention can reduce or eliminate attacks in most patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18367021     DOI: 10.1007/s11906-008-0005-2

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  18 in total

1.  Anxiety-induced hyperventilation. A common cause of symptoms in patients with hypertension.

Authors:  N M Kaplan
Journal:  Arch Intern Med       Date:  1997-05-12

2.  Clonidine-suppression test: a useful aid in the diagnosis of pheochromocytoma.

Authors:  E L Bravo; R C Tarazi; F M Fouad; D G Vidt; R W Gifford
Journal:  N Engl J Med       Date:  1981-09-10       Impact factor: 91.245

3.  Heart rate and blood pressure during placebo-associated panic attacks.

Authors:  R Balon; A Ortiz; R Pohl; V K Yeragani
Journal:  Psychosom Med       Date:  1988 Jul-Aug       Impact factor: 4.312

Review 4.  Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma.

Authors:  K Pacak; W M Linehan; G Eisenhofer; M M Walther; D S Goldstein
Journal:  Ann Intern Med       Date:  2001-02-20       Impact factor: 25.391

5.  Posture- and emotion-induced severe hypertensive paroxysms with baroreceptor dysfunction.

Authors:  O Kuchel; J R Cusson; P Larochelle; N T Buu; J Genest
Journal:  J Hypertens       Date:  1987-06       Impact factor: 4.844

Review 6.  Neurogenic essential hypertension revisited: the case for increased clinical and research attention.

Authors:  Samuel J Mann
Journal:  Am J Hypertens       Date:  2003-10       Impact factor: 2.689

7.  Paroxysmal hypertension due to sinoaortic baroreceptor denervation in humans.

Authors:  T R Aksamit; J S Floras; R G Victor; P E Aylward
Journal:  Hypertension       Date:  1987-03       Impact factor: 10.190

8.  Sustained urinary norepinephrine and epinephrine elevation in post-traumatic stress disorder.

Authors:  T R Kosten; J W Mason; E L Giller; R B Ostroff; L Harkness
Journal:  Psychoneuroendocrinology       Date:  1987       Impact factor: 4.905

Review 9.  Clinical pharmacokinetics and pharmacodynamics of carvedilol.

Authors:  T Morgan
Journal:  Clin Pharmacokinet       Date:  1994-05       Impact factor: 6.447

10.  Episodic dopamine discharge in paroxysmal hypertension. Page's syndrome revisited.

Authors:  O Kuchel; N T Buu; P Larochelle; P Hamet; J Genest
Journal:  Arch Intern Med       Date:  1986-07
View more
  18 in total

1.  Unexplained Symptomatic Paroxysmal Hypertension: a Diagnostic and Management Challenge.

Authors:  Kelly Dyer; Theresa E Vettese
Journal:  J Gen Intern Med       Date:  2019-11-08       Impact factor: 5.128

Review 2.  Labile and Paroxysmal Hypertension: Common Clinical Dilemmas in Need of Treatment Studies.

Authors:  Samuel J Mann
Journal:  Curr Cardiol Rep       Date:  2015-11       Impact factor: 2.931

Review 3.  Neurogenic hypertension: pathophysiology, diagnosis and management.

Authors:  Samuel J Mann
Journal:  Clin Auton Res       Date:  2018-07-04       Impact factor: 4.435

4.  Taking a family history of hypertension: is there patient care benefit?

Authors:  Joel Handler
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-12-17       Impact factor: 3.738

Review 5.  Labile hypertension: a new disease or a variability phenomenon?

Authors:  Elias Sanidas; Charalampos Grassos; Dimitrios P Papadopoulos; Maria Velliou; Kostas Tsioufis; Marina Mantzourani; Despoina Perrea; Dimitrios Iliopoulos; John Barbetseas; Vasilios Papademetriou
Journal:  J Hum Hypertens       Date:  2019-01-15       Impact factor: 3.012

6.  Pseudopheochromocytoma: An uncommon cause of malignant hypertension.

Authors:  S M Seck; E F Ka; A Niang; B Diouf
Journal:  Indian J Nephrol       Date:  2009-07

Review 7.  Anti-hypertensive treatment in pheochromocytoma and paraganglioma: current management and therapeutic features.

Authors:  Alberto Mazza; Michela Armigliato; Maria Cristina Marzola; Laura Schiavon; Domenico Montemurro; Giorgio Vescovo; Marco Zuin; Sotirios Chondrogiannis; Roberta Ravenni; Giuseppe Opocher; Patrick M Colletti; Domenico Rubello
Journal:  Endocrine       Date:  2013-07-02       Impact factor: 3.633

Review 8.  Pseudopheochromocytoma.

Authors:  Divya Mamilla; Melissa K Gonzales; Murray D Esler; Karel Pacak
Journal:  Endocrinol Metab Clin North Am       Date:  2019-09-18       Impact factor: 4.741

Review 9.  The clinical spectrum of labile hypertension: a management dilemma.

Authors:  Samuel J Mann
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-09       Impact factor: 3.738

10.  Psychosomatic research in hypertension: the lack of impact of decades of research and new directions to consider.

Authors:  Samuel J Mann
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-07-26       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.